3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Embolism
1
Interventions
Rivaroxaban
8
Surveys and Questionnaires
7
Heparin, Low-Molecular-Weight
5
apixaban
4
fludarabine
3
Blood Specimen Collection
3
pegfilgrastim
2
epoetin beta
2
Therapeutics
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Observation
2
Microarray Analysis
2
Melphalan
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Flow Cytometry
2
Epoetin Alfa
2
Data Collection
2
Dabigatran
2
Biopsy
2
ziprasidone
1
ribociclib
1
ravulizumab
1
palbociclib
1
oprelvekin
1
iron isomaltoside 1000
1
fludarabine phosphate
1
edoxaban
1
calcium heparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
edoxaban
×
Classical hematology
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled